In breast cancer PD-L1 expression (in tumor tissue and TIL) has been shown to be correlated with worsen clinicopathological data like larger tumor size, histologic grade III tumors, or negative hormone receptors [36]. The gene discussed is CD274; the disease is neoplasm.